Showing results (161-170 of 241) with videos related to

Sort By:
Pageof 25
Oncotarget|February 11, 2017
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitorsPaavo O Pietarinen, Christopher A Eide, Pilar Ayuda-Durán, et al.
Molecular Cancer Therapeutics|March 13, 2015
The tyrosine kinase inhibitors imatinib and dasatinib reduce myeloid suppressor cells and release effector lymphocyte responsesLisa Christiansson, Stina Söderlund, Sara Mangsbo, et al.
Clinical Pharmacology and Therapeutics|February 11, 2026
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World DataFrancesco Pignatti, Tarec Christoffer El-Galaly, Martin Kaiser, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2007
Murine models of acute neuronopathic Gaucher diseaseIda Berglin Enquist, Christophe Lo Bianco, Andreas Ooka, et al.
Mycoses|March 27, 2018
Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patientsHelena Hammarström, Anna Stjärne Aspelund, Bertil Christensson, et al.
Bone Marrow Transplantation|April 10, 2019
Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registryAnna Lübking, Arta Dreimane, Fredrik Sandin, et al.
Elife|November 6, 2024
Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy responseRebecca Warfvinge, Linda Geironson Ulfsson, Parashar Dhapola, et al.
Annals of Internal Medicine|June 14, 2016
Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Population-Based Cohort StudyTorsten Dahlén, Gustaf Edgren, Mats Lambe, et al.
Pageof 25